
Creathor Ventures
Description
Creathor Ventures is a prominent German venture capital firm based in Bad Homburg, boasting a long-standing history in the European tech ecosystem. Founded over 25 years ago, the firm primarily focuses on early-stage technology-oriented companies across the DACH region (Germany, Austria, Switzerland) and other European markets. Their investment scope spans both digital technologies, including SaaS, AI, FinTech, and e-commerce, and the life sciences sector, encompassing MedTech, Digital Health, and Biotech innovations. Creathor Ventures is recognized for its commitment to fostering innovation and supporting disruptive business models.
The firm typically engages with companies at the Seed, Series A, and Series B stages, providing not just capital but also strategic guidance and access to their extensive network. They are known for their hands-on approach, supporting portfolio companies through various growth phases, from product development and market entry to international expansion. Creathor Ventures aims to build long-term partnerships with ambitious founders who are developing technologies with significant market potential, emphasizing a collaborative relationship to accelerate growth.
The firm's typical initial investment ranges from €1 million to €5 million, demonstrating their commitment to substantial early-stage funding. They have the capacity to provide significant follow-on investments, potentially investing up to €15 million over the lifetime of a single company. Creathor Ventures has a strong track record of successful fundraises, including their Creathor V fund, which closed at €90 million. Their latest endeavor, Creathor VI, is currently targeting €150 million, underscoring their continued growth and ambition to support the next generation of European tech leaders across their target sectors.
Investor Profile
Creathor Ventures has backed more than 91 startups, with 0 new investments in the last 12 months alone. The firm has led 37 rounds, about 41% of its total and boasts 22 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Series B rounds (top funding stages).
- Majority of deals are located in Germany, Switzerland, United States.
- Strong thematic focus on Software, Health Care, Biotechnology.
- Typical check size: $1.1M – $5.4M.
Stage Focus
- Series A (32%)
- Series Unknown (25%)
- Series B (22%)
- Seed (16%)
- Series C (3%)
- Private Equity (1%)
Country Focus
- Germany (66%)
- Switzerland (10%)
- United States (8%)
- France (8%)
- Finland (4%)
- Sweden (3%)
- Austria (1%)
Industry Focus
- Software
- Health Care
- Biotechnology
- Information Technology
- Mobile
- Internet
- E-commerce
- Apps
- Saas
- Pharmaceutical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.